+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunization of chimpanzees against hiv 1 using pure recombinant antigens live vaccinia virus recombinants or a conventional inactivated virus vaccine



Immunization of chimpanzees against hiv 1 using pure recombinant antigens live vaccinia virus recombinants or a conventional inactivated virus vaccine



De-The, G (Ed ) Aids 89-90: News And Views on Research And Control Xii+294p Medsi/Mcgraw-Hill: Paris, France; New York, New York, Usa Illus Paper 207-210




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031807947

Download citation: RISBibTeXText


Related references

Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Vaccine 22(25/26): 3329-3333, 2004

Mechanism of immunity to influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins. Journal of General Virology 70: 1523-1531, 1989

A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Vaccine 11(14): 1395-1404, 1993

Influenza immunization: intranasal live vaccinia recombinant contrasted with parenteral inactivated vaccine. Vaccine 9(10): 751-756, 1991

Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus. Journal of Virology 82(21): 10896-10905, 2008

Recombinant vaccinia viruses as live virus vectors for vaccine antigens: memorandum from a WHO/USPHS/NIBSC meeting. Bulletin of the World Health Organization 63(3): 471-477, 1985

Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine. Journal of Medical Virology 50(2): 105-111, 1996

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine. Journal of Virology 80(10): 4705-4716, 2006

Active immunization against infection caused by B virus. (Herpes-virus simiae). II. Dynamics of neutralizing antibodies in rabbits immunized with inactivated vaccine and challenged with live virus. Attempts to obtain highly active antiserum against B virus. Journal of Hygiene Epidemiology Microbiology and Immunology 9(4): 487-499, 1965

Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus. Vaccine 6(3): 257-261, 1988

Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 339(2): 273-280, 2005

Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature 311(5981): 67-69, 1984

Effect of virulence on immunogenicity of single and double vaccinia virus recombinants expressing differently immunogenic antigens: antibody-response inhibition induced by immunization with a mixture of recombinants differing in virulence. Journal of General Virology 80: 2901-2908, 1999

Dna Immunization with Hepatitis C Virus (Hcv) Polycistronic Genes or Immunization by Hcv Dna Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant Hcv-Vaccinia Virus Infection in Hla-A2.1-Transgenic Mice. Journal of Virology 77(1): 382-390, 2003

DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice. Journal of Virology 77(1): 382-390, 2003